RABIPUR INACTIVATED RABIES VACCINE FOR HUMAN USE 2.5UI / ml lyophilized powder + solvent for intradermic injection solution medication leaflet

J07BG01 rabies vaccine inactivated • Antiinfectives for systemic use | Viral vaccines | Rabies vaccines

The inactivated rabies vaccine is used to prevent rabies, a fatal viral disease caused by the rabies virus, which is transmitted through the bite or scratch of an infected animal. The vaccine contains inactivated (killed) viruses that stimulate the immune system to produce antibodies against the virus, providing protection against infection.

The vaccine is administered intramuscularly, either as pre-exposure prophylaxis for individuals at high risk (such as veterinarians or travelers to endemic areas) or as post-exposure prophylaxis after contact with a suspected animal. The vaccination schedule varies depending on the situation, typically including 3-5 doses.

Common side effects include pain at the injection site, fever, headache, and fatigue. In rare cases, severe allergic reactions or neurological symptoms may occur.

The inactivated rabies vaccine is an essential measure for preventing rabies, helping to save lives and reduce the incidence of this fatal disease.

General data about RABIPUR INACTIVATED RABIES VACCINE FOR HUMAN USE 2.5UI / ml

Substance: rabies vaccine inactivated

Date of last drug list: 01-08-2018

Commercial code: W64418001

Concentration: 2.5UI / ml

Pharmaceutical form: lyophilized powder + solvent for intradermic injection solution

Quantity: 1

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).